Guggenheim initiated coverage on Twist Bioscience with a new price target

6/4/24 7:44:10 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Guggenheim initiated coverage of Twist Bioscience with a rating of Buy and set a new price target of $53.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TWST

Date	Price Target	Rating	Analyst
12/13/2024	$60.00	Outperform	Wolfe Research
6/4/2024	$53.00	Buy	Guggenheim
1/17/2024	$25.00 → $45.00	Neutral → Buy	Goldman
9/27/2023	$27.00	Buy	Berenberg
1/5/2023	$33.00	Sector Outperform	Scotiabank
1/3/2023	$28.00 → $36.00	In-line → Outperform	Evercore ISI
3/2/2022		Outperform	Cowen
2/7/2022	$130.00 → $75.00	Overweight	Barclays